Abstract Details
| Konrad Rejdak, PhD (Medical Univeristy of Lublin) | Dr. Rejdak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck, Biogen, Bayer, Sanofi, Teva, Roche, Takeda. Dr. Rejdak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck, Biogen, Bayer, Sanofi, Teva, Roche, Takeda. |
| Robert Rejdak | No disclosure on file |
| Malgorzata Chlebicka (GSK Commercial Sp. z.o.o.) | No disclosure on file |
| Pawel Grieb (Massakowski MRC, Pol Acad Science) | No disclosure on file |
| Zbigniew Stelmasiak, PhD (Katedra i Klinika Neurologii) | No disclosure on file |
| No disclosure on file |